Literature DB >> 10500927

Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness.

P E Cryer1.   

Abstract

Ultimately traceable to neural glucose deprivation, symptoms of hypoglycemia include neurogenic (autonomic) and neuroglycopenic symptoms. Neurogenic symptoms (tremulousness, palpitations, anxiety, sweating, hunger, paresthesias) are the results of the perception of physiologic changes caused by the autonomic nervous system's response to hypoglycemia. Neuroglycopenic symptoms (confusion, sensation of warmth, weakness or fatigue, severe cognitive failure, seizure, coma) are the results of brain glucose deprivation itself. Glycemic thresholds for symptoms of hypoglycemia shift to lower plasma glucose concentrations following recent episodes of hypoglycemia, leading to the syndrome of hypoglycemia unawareness--loss of the warning symptoms of developing hypoglycemia. Thus, patients with recurrent hypoglycemia (e.g., those with tightly controlled diabetes or with an insulinoma) often tolerate abnormally low plasma glucose concentrations without symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500927     DOI: 10.1016/s0889-8529(05)70084-0

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  30 in total

1.  Best practice No 173: clinical and laboratory investigation of adult spontaneous hypoglycaemia.

Authors:  R Gama; J D Teale; V Marks
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

Review 2.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

3.  Hindbrain cytoglucopenia-induced increases in systemic blood glucose levels by 2-deoxyglucose depend on intact astrocytes and adenosine release.

Authors:  Richard C Rogers; Sue Ritter; Gerlinda E Hermann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-13       Impact factor: 3.619

4.  Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Authors:  Oleg Otlivanchik; Nicole M Sanders; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-28       Impact factor: 3.619

5.  Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study.

Authors:  Lakshmi G Singh; David L Levitt; Medha Satyarengga; Lillian Pinault; Min Zhan; John D Sorkin; Jeffrey C Fink; Guillermo E Umpierrez; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2019-11-28

6.  The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System.

Authors:  Elias K Spanakis; David L Levitt; Tariq Siddiqui; Lakshmi G Singh; Lillian Pinault; John Sorkin; Guillermo E Umpierrez; Jeffrey C Fink
Journal:  J Diabetes Sci Technol       Date:  2017-12-13

7.  Streptozotocin Induced Acute Clinical Effects in Rabbits (Oryctolagus cuniculus).

Authors:  Masood Saleem Mir; Mohammad Maqbool Darzi; Omer Khalil Baba; Hilal Musadiq Khan; Shayaib Ahmad Kamil; Asif Hassan Sofi; Sarfraz Ahmad Wani
Journal:  Iran J Pathol       Date:  2015

8.  Endogenous hyperinsulinemic hypoglycemia: diagnostic strategies, predictive features of malignancy and long-term survival.

Authors:  M Queiroz Almeida; M Cerqueira Cesar Machado; M L Correa-Giannella; D Giannella-Neto; M A Albergaria Pereira
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 9.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

10.  Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes.

Authors:  M L Koivikko; M Karsikas; P I Salmela; J S Tapanainen; A Ruokonen; T Seppänen; H V Huikuri; J S Perkiömäki
Journal:  Diabetologia       Date:  2007-12-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.